Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 9/20 | 0.37 |
| ▸ | IL1B | P01584 | 2/20 | 0.35 |
| ▸ | LCK | P06239 | 11/20 | 0.35 |
| ▸ | CASP3 | P42574 | 2/20 | 0.35 |
| ▸ | CASP8 | Q14790 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7735511 | 0.88 | CASP1 (0.37) | CASP1IL1BLCKCASP3CASP8 | |
| SCHEMBL7740043 | 0.83 | LCK (0.35) | CASP1IL1BLCKCASP3CASP8 | |
| SCHEMBL8412036 | 0.80 | CASP1 (0.38) | CASP1IL1BLCKCASP3CASP8 | |
| SCHEMBL1410039 | 0.80 | CASP1 (0.38) | CASP1IL1BLCKCASP3CASP8 | |
| SCHEMBL647407 | 0.79 | CASP1 (0.44) | CASP1IL1BLCKCASP3CASP8 | |
| SCHEMBL645919 | 0.79 | CASP1 (0.44) | CASP1IL1BLCKCASP3CASP8 | |
| SCHEMBL1409981 | 0.78 | CASP1 (0.41) | CASP1IL1BLCK | |
| SCHEMBL7257607 | 0.77 | CASP1 (0.40) | CASP1IL1BLCK | |
| SCHEMBL2216776 | 0.77 | CASP1 (0.39) | CASP1IL1BLCK | |
| SCHEMBL2220412 | 0.76 | CASP1 (0.43) | CASP1IL1BLCKCASP3CASP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6008217-A | AN ENZYME INHIBITOR AGAINST INTERLEUKIN-1B, FOR TREATING APOPTOSIS-MEDIATED DISEASES, INCLUDING INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES, PROLIFERATIVE DISORDERS, INFECTIOUS DISEASES, AND DEGENERATIVE DISEASES | VERTEX PHARMACEUTICALS INCORPORATED (US) | 1999-12-28 | — | — | US | disclosed |